This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Illinois Chief District Judge holds in abeyance all DOJ litigation due to government shutdown

( October 3, 2025, 08:53 GMT | Official Statement) -- MLex Summary: The Chief District Judge for the US District Court for the Northern District of Illinois has issued a general order suspending, postponing and holding in abeyance all civil litigation involving as a party the United States of America, its agencies, its officers or employees, and/or any other party represented by the Department of Justice or the United States Attorney’s Office until funding for federal government operations is fully restored. The order, effective Oct. 1, suspends and continues, during the stay, any and all events and deadlines in the affected civil litigation, including but not limited to any scheduled proceedings, hearings, and/or discovery and pleading dates. Currently pending before the court is a resolution on the Federal Trade Commission's challenge of GTCR’s acquisition of Surmodics.See order attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login